欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/0323/002
药品名称Valcyte 50 mg/ml powder for oral solution
活性成分
    • valganciclovir 50.0 mg/ml
剂型Powder for oral solution
上市许可持有人Roche Nederland BV Postbus 44 3440 AA Woerden The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Valcyte 50 mg/ml poeder voor orale oplossing
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • Luxembourg (LU)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Poland (PL)
    • Lithuania (LT)
    • Hungary (HU)
    • Cyprus (CY)
    • Czechia (CZ)
    • Slovenia (SI)
    • Croatia (HR)
    • Latvia (LV)
    • Norway (NO)
    • Finland (FI)
许可日期2008/01/17
最近更新日期2023/12/19
药物ATC编码
    • J05AB14 valganciclovir
申请类型
  • TypeLevel1:Line Extension
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase